XYRA, Announces XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices 07.08.2025 - 18:04:21 XYRA United Kingdom England California View original content:https://www.prnewswire.co.uk/news-releases/xyra-announces-fda-label-guidance-for-managing-atrial-fibrillation-with-budiodarone-and-wearable-monitoring-devices-302276953.html
